In a β-cell polyoma middle T antigen (PyMT) transgenic model, Trp53 deletion yielded primary pNETs in ~20% of mice while concurrent deletion of Ink4a/Arf doubled tumor incidence relative to loss of either tumor suppressor alone [73]. The gene discussed is CDKN2A; the disease is neoplasm.